These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 25385346)

  • 1. Incidence of defibrillator shocks after elective generator exchange following uneventful first battery life.
    Merchant FM; Jones P; Wehrenberg S; Lloyd MS; Saxon LA
    J Am Heart Assoc; 2014 Nov; 3(6):e001289. PubMed ID: 25385346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
    Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database.
    Krahn AD; Lee DS; Birnie D; Healey JS; Crystal E; Dorian P; Simpson CS; Khaykin Y; Cameron D; Janmohamed A; Yee R; Austin PC; Chen Z; Hardy J; Tu JV;
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):136-42. PubMed ID: 21325209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time dependence of risks and benefits in pediatric primary prevention implantable cardioverter-defibrillator therapy.
    DeWitt ES; Triedman JK; Cecchin F; Mah DY; Abrams DJ; Walsh EP; Gauvreau K; Alexander ME
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1057-63. PubMed ID: 25262116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
    J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased delivery of inappropriate shocks achieved by remote monitoring of ICD: a substudy of the ECOST trial.
    Guédon-Moreau L; Kouakam C; Klug D; Marquié C; Brigadeau F; Boulé S; Blangy H; Lacroix D; Clémenty J; Sadoul N; Kacet S
    J Cardiovasc Electrophysiol; 2014 Jul; 25(7):763-70. PubMed ID: 24602062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
    Syska P; Przybylski A; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Gepner K; Pytkowski M; Kowalik I; Maczyńska-Mazuruk R; Ruzyłło W; Szwed H
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):883-9. PubMed ID: 20132378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.
    Alam MB; Munir MB; Rattan R; Flanigan S; Adelstein E; Jain S; Saba S
    Europace; 2014 Feb; 16(2):246-51. PubMed ID: 24099864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the need of elective implantable cardioverter-defibrillator generator replacement in primary prevention patients without prior appropriate ICD therapy.
    Yap SC; Schaer BA; Bhagwandien RE; Kühne M; Dabiri Abkenari L; Osswald S; Szili-Torok T; Sticherling C; Theuns DA
    Heart; 2014 Aug; 100(15):1188-92. PubMed ID: 24993502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of implantable cardioverter defibrillator shocks during the first year.
    Dougherty CM; Hunziker J
    J Cardiovasc Nurs; 2009; 24(1):21-8; quiz 29-30. PubMed ID: 19114797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillator therapy before death: high risk for painful shocks at end of life.
    Kinch Westerdahl A; Sjöblom J; Mattiasson AC; Rosenqvist M; Frykman V
    Circulation; 2014 Jan; 129(4):422-9. PubMed ID: 24243857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
    Kron J; Sauer W; Schuller J; Bogun F; Crawford T; Sarsam S; Rosenfeld L; Mitiku TY; Cooper JM; Mehta D; Greenspon AJ; Ortman M; Delurgio DB; Valadri R; Narasimhan C; Swapna N; Singh JP; Danik S; Markowitz SM; Almquist AK; Krahn AD; Wolfe LG; Feinstein S; Ellenbogen KA
    Europace; 2013 Mar; 15(3):347-54. PubMed ID: 23002195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of premature battery depletion in a large multicentre registry of subcutaneous cardioverter-defibrillator patients.
    Wörmann J; Strik M; Jurisic S; Stout K; Elrefai M; Becher N; Schaer B; van Stipdonk A; Srinivasan NT; Ploux S; Breitenstein A; Kron J; Roberts PR; Toennis T; Linz D; Dulai R; Hermes-Laufer J; Koneru J; Erküner Ö; Dittrich S; van den Bruck JH; Schipper JH; Sultan A; Rosenberger KD; Steven D; Lüker J
    Europace; 2024 Jul; 26(7):. PubMed ID: 38885309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of premature battery depletion in a large multicentre registry of subcutaneous cardioverter-defibrillator patients.
    Wörmann J; Strik M; Jurisic S; Stout K; Elrefai M; Becher N; Schaer B; van Stipdonk A; Srinivasan NT; Ploux S; Breitenstein A; Kron J; Roberts PR; Toennis T; Linz D; Dulai R; Hermes-Laufer J; Koneru J; Erküner Ö; Dittrich S; van den Bruck JH; Schipper JH; Sultan A; Rosenberger KD; Steven D; Lüker J
    Europace; 2024 Jul; 26(7):. PubMed ID: 39082706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population.
    Buber J; Luria D; Gurevitz O; Bar-Lev D; Eldar M; Glikson M
    Europace; 2014 Feb; 16(2):227-34. PubMed ID: 24108231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and financial impact of implantable cardioverter-defibrillator patients without interventions 5 years after implantation.
    Reichlin T; Kühne M; Sticherling C; Osswald S; Schaer B
    QJM; 2011 Oct; 104(10):849-57. PubMed ID: 21624895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial.
    Kloppe A; Proclemer A; Arenal A; Lunati M; Martìnez Ferrer JB; Hersi A; Gulaj M; Wijffels MC; Santi E; Manotta L; Mangoni L; Gasparini M
    Circulation; 2014 Jul; 130(4):308-14. PubMed ID: 24838360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of Subcutaneous Implantable Cardioverter Defibrillator Implantation in Patients with End-Stage Renal Disease on Dialysis.
    El-Chami MF; Levy M; Kelli HM; Casey M; Hoskins MH; Goyal A; Langberg JJ; Patel A; Delurgio D; Lloyd MS; Leon AR; Merchant FM
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):900-904. PubMed ID: 25952566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.